nodes	percent_of_prediction	percent_of_DWPC	metapath
Drostanolone—SHBG—hypothyroidism	0.883	1	CbGaD
Drostanolone—SHBG—seminiferous tubule of testis—hypothyroidism	0.0208	0.191	CbGeAlD
Drostanolone—CYP19A1—corpus luteum—hypothyroidism	0.0199	0.183	CbGeAlD
Drostanolone—CYP19A1—seminiferous tubule of testis—hypothyroidism	0.0169	0.155	CbGeAlD
Drostanolone—AR—seminiferous tubule of testis—hypothyroidism	0.0149	0.137	CbGeAlD
Drostanolone—SHBG—cardiovascular system—hypothyroidism	0.00194	0.0178	CbGeAlD
Drostanolone—SHBG—gonad—hypothyroidism	0.00176	0.0162	CbGeAlD
Drostanolone—SHBG—pituitary gland—hypothyroidism	0.00172	0.0158	CbGeAlD
Drostanolone—SHBG—adrenal gland—hypothyroidism	0.00154	0.0141	CbGeAlD
Drostanolone—SHBG—blood—hypothyroidism	0.00153	0.0141	CbGeAlD
Drostanolone—AR—adrenal cortex—hypothyroidism	0.00153	0.014	CbGeAlD
Drostanolone—SHBG—thyroid gland—hypothyroidism	0.00148	0.0136	CbGeAlD
Drostanolone—AR—heart—hypothyroidism	0.00148	0.0136	CbGeAlD
Drostanolone—SHBG—female gonad—hypothyroidism	0.00143	0.0132	CbGeAlD
Drostanolone—CYP19A1—gonad—hypothyroidism	0.00143	0.0131	CbGeAlD
Drostanolone—AR—cardiovascular system—hypothyroidism	0.00139	0.0128	CbGeAlD
Drostanolone—SHBG—testis—hypothyroidism	0.00127	0.0117	CbGeAlD
Drostanolone—AR—gonad—hypothyroidism	0.00126	0.0116	CbGeAlD
Drostanolone—CYP19A1—adrenal gland—hypothyroidism	0.00124	0.0114	CbGeAlD
Drostanolone—CYP19A1—blood—hypothyroidism	0.00124	0.0114	CbGeAlD
Drostanolone—AR—pituitary gland—hypothyroidism	0.00123	0.0113	CbGeAlD
Drostanolone—CYP19A1—thyroid gland—hypothyroidism	0.0012	0.011	CbGeAlD
Drostanolone—SHBG—liver—hypothyroidism	0.0012	0.011	CbGeAlD
Drostanolone—SHBG—cerebellum—hypothyroidism	0.00117	0.0108	CbGeAlD
Drostanolone—CYP19A1—female gonad—hypothyroidism	0.00116	0.0107	CbGeAlD
Drostanolone—AR—adrenal gland—hypothyroidism	0.0011	0.0101	CbGeAlD
Drostanolone—AR—blood—hypothyroidism	0.0011	0.0101	CbGeAlD
Drostanolone—AR—thyroid gland—hypothyroidism	0.00106	0.00978	CbGeAlD
Drostanolone—CYP19A1—testis—hypothyroidism	0.00103	0.00946	CbGeAlD
Drostanolone—AR—female gonad—hypothyroidism	0.00103	0.00945	CbGeAlD
Drostanolone—Methyltestosterone—SHBG—hypothyroidism	0.00101	0.343	CrCbGaD
Drostanolone—CYP19A1—liver—hypothyroidism	0.000973	0.00895	CbGeAlD
Drostanolone—AR—testis—hypothyroidism	0.000911	0.00838	CbGeAlD
Drostanolone—AR—liver—hypothyroidism	0.000861	0.00792	CbGeAlD
Drostanolone—AR—Nongenotropic Androgen signaling—SHBG—hypothyroidism	0.000734	0.14	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptors—THRA—hypothyroidism	0.000733	0.14	CbGpPWpGaD
Drostanolone—Estradiol—SHBG—hypothyroidism	0.00073	0.248	CrCbGaD
Drostanolone—Progesterone—SHBG—hypothyroidism	0.00062	0.21	CrCbGaD
Drostanolone—Testosterone—SHBG—hypothyroidism	0.000586	0.199	CrCbGaD
Drostanolone—AR—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.000579	0.11	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptors—THRB—hypothyroidism	0.000472	0.09	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.000373	0.0712	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—NKX2-5—hypothyroidism	0.000285	0.0543	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—BGLAP—hypothyroidism	0.000241	0.046	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.000237	0.0451	CbGpPWpGaD
Drostanolone—CYP19A1—Endogenous sterols—POMC—hypothyroidism	0.000161	0.0306	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—ZNF764—hypothyroidism	0.000155	0.0296	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000153	0.0291	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—VAV3—hypothyroidism	0.000134	0.0255	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—hypothyroidism	0.00012	0.0229	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—THRA—hypothyroidism	0.0001	0.0191	CbGpPWpGaD
Drostanolone—AR—Gene Expression—ZNF764—hypothyroidism	7.48e-05	0.0143	CbGpPWpGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	7.46e-05	0.0142	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—NKX2-5—hypothyroidism	7.13e-05	0.0136	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—THRB—hypothyroidism	6.45e-05	0.0123	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—AVP—hypothyroidism	6.08e-05	0.0116	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	6.05e-05	0.0115	CbGpPWpGaD
Drostanolone—AR—Gene Expression—THRA—hypothyroidism	4.82e-05	0.00918	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—IYD—hypothyroidism	3.79e-05	0.00723	CbGpPWpGaD
Drostanolone—AR—Gene Expression—NKX2-5—hypothyroidism	3.43e-05	0.00654	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	3.3e-05	0.0063	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ATP5O—hypothyroidism	3.22e-05	0.00614	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—POMC—hypothyroidism	3.21e-05	0.00613	CbGpPWpGaD
Drostanolone—AR—Gene Expression—THRB—hypothyroidism	3.1e-05	0.00592	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—TPO—hypothyroidism	3.03e-05	0.00578	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	2.81e-05	0.00535	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—TSHB—hypothyroidism	1.4e-05	0.00267	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PIK3C2A—hypothyroidism	1.25e-05	0.00238	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.23e-05	0.00235	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SLC5A5—hypothyroidism	1.05e-05	0.002	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—POMC—hypothyroidism	5.5e-06	0.00105	CbGpPWpGaD
